Kevin Haag, DPM
Podiatrist · College Dale, TNNPI 1174044010
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,489 of the $2,380 with a category attached, or 62.6%. Pinnacle, Inc accounts for 63.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $2,099 and has fallen 96.4% since, to $76 in 2025.
Across 21 payments — averaging $113.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$2K
- Amgen$123
- TEI Medical Inc.$122
- AbbVie$111
- Acell, Inc.$101
- Osteomed LLC$99
- plus $316 from 8 others
What the payments were for
- Food & beverage$89137%
- Education$1,48963%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 3 | $1,508 |
| Amgen | 1 | $123 |
| TEI Medical Inc. | 1 | $122 |
| AbbVie | 2 | $111 |
| Acell, Inc. | 1 | $101 |
| Osteomed LLC | 1 | $99 |
| Mimedx Group, Inc. | 5 | $76 |
| Medtronic | 1 | $76 |
| Heron Therapeutics, Inc. | 1 | $72 |
| Johnson & Johnson | 1 | $30 |
| Stryker | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Bioventus LLC | 1 | $13 |
| Treace Medical Concepts, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RAYOS$370
- PRIMATRIX$122
- TCC-EZ$122
- AMNIOEXCEL$122
How this compares
$2,380 in reported general payments places this provider in the 65th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 12 | $209 |
| Cephalexin | 21 | $186 |
| Meloxicam | 21 | $19 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in College Dale
- Jeffrey LovelandSparta$809K
- Michael KingNashville$190K
- Penninah KumarMt Juliet$72K
- James HarrisTrenton$49K
- Matthew NeuhausSmyrna$33K
- Paul HutchisonMemphis$17K
- Sam BazrafshanChattanooga$16K
- Abshan MalikKnoxville$13K
- Christopher HendrixBartlett$13K
- Damieon BrownJasper$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.